Antimicrobial Drug and Vaccine Shortages Threaten Global Health Security
Category: Resource Management · Effect: Strong effect · Year: 2021
Disruptions in the supply chain for essential antimicrobial drugs and vaccines, driven by market size, manufacturing flaws, and global production concentration, have far-reaching consequences beyond individual patient care, impacting public health and exacerbating antimicrobial resistance.
Design Takeaway
Design for supply chain robustness and consider the broader societal impact of resource scarcity in critical product development.
Why It Matters
Understanding the systemic causes and broad impacts of drug and vaccine shortages is crucial for designing resilient healthcare systems and supply chains. This research highlights the need for proactive strategies to mitigate risks associated with resource scarcity in critical medical supplies.
Key Finding
Shortages of vital medicines and vaccines are a significant global problem, stemming from complex supply chain issues and leading to worse health outcomes, increased drug resistance, and public distrust.
Key Findings
- Antimicrobial drugs and vaccines are among the most frequently reported drug shortages.
- Multiple factors contribute to shortages, including manufacturing defects, quality control issues, raw material scarcity, and economic pressures.
- Shortages lead to the use of less effective or more harmful alternative treatments, increasing costs and contributing to antimicrobial resistance.
- Vaccine shortages can fuel public health controversies and undermine vaccination programs.
- These shortages pose a global threat due to the transmissibility of infectious diseases.
Research Evidence
Aim: To investigate the causes and multifaceted impacts of antimicrobial drug and vaccine shortages on individual and population health, and to propose coordinated responses.
Method: Literature review and synthesis of existing data on drug shortages.
Procedure: The study analyzes reported causes of drug shortages, including manufacturing issues, quality control changes, raw material scarcity, market concentration, and profit margin pressures. It then examines the consequences for patient outcomes, antimicrobial resistance, and public health, considering the 'herd effect'. Finally, it suggests potential solutions and the need for international cooperation.
Context: Global healthcare and pharmaceutical supply chains.
Design Principle
Prioritize supply chain resilience and redundancy for essential resources to ensure public health security.
How to Apply
When designing products or systems that rely on critical, potentially scarce resources, incorporate redundancy, explore alternative material sourcing, and consider distributed manufacturing models.
Limitations
The study relies on existing reported data, which may not capture all instances or causes of shortages. The proposed solutions require significant international cooperation, which can be challenging to implement.
Student Guide (IB Design Technology)
Simple Explanation: When important medicines or vaccines aren't available, it's not just one person who suffers; it affects everyone because diseases can spread more easily and treatments become less effective, leading to bigger health problems for whole communities.
Why This Matters: This research shows that the availability of resources is a critical design consideration, especially for products that impact public health. It encourages designers to think beyond the immediate user to the wider societal implications of their work.
Critical Thinking: How can designers proactively mitigate the risks of resource scarcity in their design projects, especially when dealing with complex global supply chains?
IA-Ready Paragraph: The research by Béraud (2021) highlights the critical nature of resource management in ensuring the availability of essential products like antimicrobial drugs and vaccines. Their findings underscore that shortages in these areas have profound implications for public health, contributing to antimicrobial resistance and undermining community well-being. This emphasizes the need for designers to consider supply chain resilience and potential resource scarcity as integral aspects of their design process, particularly for products with significant societal impact.
Project Tips
- When researching a product, consider not just its function but also the availability and stability of its components and manufacturing processes.
- Investigate potential single points of failure in your design's supply chain or resource dependencies.
How to Use in IA
- Reference this study when discussing the importance of supply chain stability, resource availability, or the broader impact of product design on public health and resource management.
Examiner Tips
- Demonstrate an understanding of how resource availability and supply chain issues can influence the viability and impact of a design solution.
Independent Variable: ["Factors contributing to drug/vaccine shortages (e.g., manufacturing flaws, market size, raw material scarcity)."]
Dependent Variable: ["Impact on individual patient outcomes.","Impact on antimicrobial resistance (AMR).","Impact on population health (herd effect).","Public health controversies."]
Controlled Variables: ["Global economic conditions.","Regulatory environments.","Disease prevalence."]
Strengths
- Addresses a critical and timely global health issue.
- Synthesizes multiple causes and consequences of shortages.
- Proposes a framework for coordinated action.
Critical Questions
- What are the ethical considerations for designers when a product's availability is threatened by resource scarcity?
- How can design innovation contribute to more resilient and distributed manufacturing models for essential goods?
Extended Essay Application
- Investigate the supply chain for a specific product and identify potential vulnerabilities to resource scarcity, proposing design solutions to enhance resilience.
Source
Shortages Without Frontiers: Antimicrobial Drug and Vaccine Shortages Impact Far Beyond the Individual! · Frontiers in Medicine · 2021 · 10.3389/fmed.2021.593712